APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blood Bank (Blood Banking)

This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.

Selected research

Market Outlook & Growth Opportunities

Global Blood Bank (Blood Banking) Market Outlook and Growth Opportunities 2026

Report ID 173893670426 December 2025211 pages

Choose your research edition.

Industry ResearchBlood Bank (Blood Banking) Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Bank (Blood Banking) Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Blood Bank (Blood Banking) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Bank (Blood Banking) Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Bank (Blood Banking) Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

This report studies the Blood Banking market, and blood banking refers to the process of collecting, separating, and storing blood. A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a division of a hospital where the storage of blood product occurs and where proper testing is performed (to reduce the risk of transfusion related adverse events). However, it sometimes refers to a collection center, and indeed some hospitals also perform collection.

North America is the largest consumption place, with a consumption market share more than 35%, It was followed by Europe with 25%. Shire (Baxalta), CSL and Grifols are the top 3 players of Blood Bank market, and they had a nearly 60% combined market share.

This report provides an overview of the global Blood Bank (Blood Banking) market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Blood Bank (Blood Banking) and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Blood Bank (Blood Banking) revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Blood Bank (Blood Banking) market.

Blood Bank (Blood Banking) Segment by Company

American Red Cross

Japan Red Cross Society

New York Blood Center

Sanquin Blood Supply Foundation

America’s Blood Centers

Canadian Blood Services

Shire (Baxalta)

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Sichuan Yuanda Shuyang

Abbott

Beckman Coulter

BD

Bio-Rad Laboratories

bioMérieux

Cerus

Haemonetics

Immucor

Fresenius Kabi

MacoPharma

Ortho-Clinical

Terumo BCT

Blood Bank (Blood Banking) Segment by Type

Whole Blood

Red Blood Cell

Platelet

Plasma

White Blood Cell

Blood Bank (Blood Banking) Segment by Application

Hospital

Clinic

Others

Blood Bank (Blood Banking) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Blood Bank (Blood Banking) status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Blood Bank (Blood Banking) key companies, revenue, market share, and recent developments.

3. To split the Blood Bank (Blood Banking) breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Blood Bank (Blood Banking) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Blood Bank (Blood Banking) significant trends, drivers, influence factors in global and regions.

6. To analyze Blood Bank (Blood Banking) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Bank (Blood Banking) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Bank (Blood Banking) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Bank (Blood Banking).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Blood Bank (Blood Banking) industry.

Chapter 3: Detailed analysis of Blood Bank (Blood Banking) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Blood Bank (Blood Banking) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Blood Bank (Blood Banking) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Blood Bank (Blood Banking) Industry Trends Table 2. Blood Bank (Blood Banking) Industry Drivers Table 3. Blood Bank (Blood Banking) Industry Opportunities and Challenges Table 4. Blood Bank (Blood Banking) Industry Restraints Table 5. Global Blood Bank (Blood Banking) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Blood Bank (Blood Banking) Revenue Share by Company (2021-2026) Table 7. Global Blood Bank (Blood Banking) Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Blood Bank (Blood Banking) Key Company Manufacturing Base & Headquarters Table 9. Global Blood Bank (Blood Banking) Company, Product Type & Application Table 10. Global Blood Bank (Blood Banking) Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Blood Bank (Blood Banking) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Whole Blood Table 15. Significant Companies of Red Blood Cell Table 16. Significant Companies of Platelet Table 17. Significant Companies of Plasma Table 18. Significant Companies of White Blood Cell Table 19. Global Blood Bank (Blood Banking) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Blood Bank (Blood Banking) Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Blood Bank (Blood Banking) Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Blood Bank (Blood Banking) Sales Value Share by Type (2021-2026) Table 23. Global Blood Bank (Blood Banking) Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospital Table 25. Significant Companies of Clinic Table 26. Significant Companies of Others Table 27. Global Blood Bank (Blood Banking) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Blood Bank (Blood Banking) Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Blood Bank (Blood Banking) Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Blood Bank (Blood Banking) Sales Value Share by Application (2021-2026) Table 31. Global Blood Bank (Blood Banking) Sales Value Share by Application (2027-2032) Table 32. Global Blood Bank (Blood Banking) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Blood Bank (Blood Banking) Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Blood Bank (Blood Banking) Sales Value Share by Region (2021-2026) Table 35. Global Blood Bank (Blood Banking) Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Blood Bank (Blood Banking) Sales Value Share by Region (2027-2032) Table 37. Global Blood Bank (Blood Banking) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Blood Bank (Blood Banking) Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Blood Bank (Blood Banking) Sales Value Market Share by Country (2021-2026) Table 40. Global Blood Bank (Blood Banking) Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Blood Bank (Blood Banking) Sales Value Market Share by Country (2027-2032) Table 42. American Red Cross Company Information Table 43. American Red Cross Business Overview Table 44. American Red Cross Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. American Red Cross Blood Bank (Blood Banking) Product Portfolio Table 46. American Red Cross Recent Development Table 47. Japan Red Cross Society Company Information Table 48. Japan Red Cross Society Business Overview Table 49. Japan Red Cross Society Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Japan Red Cross Society Blood Bank (Blood Banking) Product Portfolio Table 51. Japan Red Cross Society Recent Development Table 52. New York Blood Center Company Information Table 53. New York Blood Center Business Overview Table 54. New York Blood Center Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. New York Blood Center Blood Bank (Blood Banking) Product Portfolio Table 56. New York Blood Center Recent Development Table 57. Sanquin Blood Supply Foundation Company Information Table 58. Sanquin Blood Supply Foundation Business Overview Table 59. Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Product Portfolio Table 61. Sanquin Blood Supply Foundation Recent Development Table 62. America’s Blood Centers Company Information Table 63. America’s Blood Centers Business Overview Table 64. America’s Blood Centers Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. America’s Blood Centers Blood Bank (Blood Banking) Product Portfolio Table 66. America’s Blood Centers Recent Development Table 67. Canadian Blood Services Company Information Table 68. Canadian Blood Services Business Overview Table 69. Canadian Blood Services Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Canadian Blood Services Blood Bank (Blood Banking) Product Portfolio Table 71. Canadian Blood Services Recent Development Table 72. Shire (Baxalta) Company Information Table 73. Shire (Baxalta) Business Overview Table 74. Shire (Baxalta) Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Shire (Baxalta) Blood Bank (Blood Banking) Product Portfolio Table 76. Shire (Baxalta) Recent Development Table 77. CSL Company Information Table 78. CSL Business Overview Table 79. CSL Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. CSL Blood Bank (Blood Banking) Product Portfolio Table 81. CSL Recent Development Table 82. Grifols Company Information Table 83. Grifols Business Overview Table 84. Grifols Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Grifols Blood Bank (Blood Banking) Product Portfolio Table 86. Grifols Recent Development Table 87. Octapharma Company Information Table 88. Octapharma Business Overview Table 89. Octapharma Blood Bank (Blood Banking) Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Octapharma Blood Bank (Blood Banking) Product Portfolio Table 91. Octapharma Recent Development Table 92. Kedrion Company Information Table 93. Kedrion Business Overview Table 94. Kedrion Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 95. Kedrion Blood Bank (Blood Banking) Product Portfolio Table 96. Kedrion Recent Development Table 97. LFB Group Company Information Table 98. LFB Group Business Overview Table 99. LFB Group Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 100. LFB Group Blood Bank (Blood Banking) Product Portfolio Table 101. LFB Group Recent Development Table 102. Biotest Company Information Table 103. Biotest Business Overview Table 104. Biotest Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 105. Biotest Blood Bank (Blood Banking) Product Portfolio Table 106. Biotest Recent Development Table 107. BPL Company Information Table 108. BPL Business Overview Table 109. BPL Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 110. BPL Blood Bank (Blood Banking) Product Portfolio Table 111. BPL Recent Development Table 112. RAAS Company Information Table 113. RAAS Business Overview Table 114. RAAS Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 115. RAAS Blood Bank (Blood Banking) Product Portfolio Table 116. RAAS Recent Development Table 117. CBPO Company Information Table 118. CBPO Business Overview Table 119. CBPO Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 120. CBPO Blood Bank (Blood Banking) Product Portfolio Table 121. CBPO Recent Development Table 122. Hualan Bio Company Information Table 123. Hualan Bio Business Overview Table 124. Hualan Bio Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 125. Hualan Bio Blood Bank (Blood Banking) Product Portfolio Table 126. Hualan Bio Recent Development Table 127. Sichuan Yuanda Shuyang Company Information Table 128. Sichuan Yuanda Shuyang Business Overview Table 129. Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 130. Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Product Portfolio Table 131. Sichuan Yuanda Shuyang Recent Development Table 132. Abbott Company Information Table 133. Abbott Business Overview Table 134. Abbott Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 135. Abbott Blood Bank (Blood Banking) Product Portfolio Table 136. Abbott Recent Development Table 137. Beckman Coulter Company Information Table 138. Beckman Coulter Business Overview Table 139. Beckman Coulter Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 140. Beckman Coulter Blood Bank (Blood Banking) Product Portfolio Table 141. Beckman Coulter Recent Development Table 142. BD Company Information Table 143. BD Business Overview Table 144. BD Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 145. BD Blood Bank (Blood Banking) Product Portfolio Table 146. BD Recent Development Table 147. Bio-Rad Laboratories Company Information Table 148. Bio-Rad Laboratories Business Overview Table 149. Bio-Rad Laboratories Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 150. Bio-Rad Laboratories Blood Bank (Blood Banking) Product Portfolio Table 151. Bio-Rad Laboratories Recent Development Table 152. bioMérieux Company Information Table 153. bioMérieux Business Overview Table 154. bioMérieux Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 155. bioMérieux Blood Bank (Blood Banking) Product Portfolio Table 156. bioMérieux Recent Development Table 157. Cerus Company Information Table 158. Cerus Business Overview Table 159. Cerus Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 160. Cerus Blood Bank (Blood Banking) Product Portfolio Table 161. Cerus Recent Development Table 162. Haemonetics Company Information Table 163. Haemonetics Business Overview Table 164. Haemonetics Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 165. Haemonetics Blood Bank (Blood Banking) Product Portfolio Table 166. Haemonetics Recent Development Table 167. Immucor Company Information Table 168. Immucor Business Overview Table 169. Immucor Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 170. Immucor Blood Bank (Blood Banking) Product Portfolio Table 171. Immucor Recent Development Table 172. Fresenius Kabi Company Information Table 173. Fresenius Kabi Business Overview Table 174. Fresenius Kabi Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 175. Fresenius Kabi Blood Bank (Blood Banking) Product Portfolio Table 176. Fresenius Kabi Recent Development Table 177. MacoPharma Company Information Table 178. MacoPharma Business Overview Table 179. MacoPharma Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 180. MacoPharma Blood Bank (Blood Banking) Product Portfolio Table 181. MacoPharma Recent Development Table 182. Ortho-Clinical Company Information Table 183. Ortho-Clinical Business Overview Table 184. Ortho-Clinical Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 185. Ortho-Clinical Blood Bank (Blood Banking) Product Portfolio Table 186. Ortho-Clinical Recent Development Table 187. Terumo BCT Company Information Table 188. Terumo BCT Business Overview Table 189. Terumo BCT Blood Bank (Blood Banking) Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 190. Terumo BCT Blood Bank (Blood Banking) Product Portfolio Table 191. Terumo BCT Recent Development Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Blood Bank (Blood Banking) Product Image Figure 2. Global Blood Bank (Blood Banking) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Bank (Blood Banking) Market Size (2021-2032) & (US$ Million) Figure 4. Global Blood Bank (Blood Banking) Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Whole Blood Image Figure 8. Red Blood Cell Image Figure 9. Platelet Image Figure 10. Plasma Image Figure 11. White Blood Cell Image Figure 12. Global Blood Bank (Blood Banking) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Blood Bank (Blood Banking) Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Blood Bank (Blood Banking) Sales Value Share by Type (2021-2032) Figure 15. Hospital Image Figure 16. Clinic Image Figure 17. Others Image Figure 18. Global Blood Bank (Blood Banking) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Blood Bank (Blood Banking) Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Blood Bank (Blood Banking) Sales Value Share by Application (2021-2032) Figure 21. Global Blood Bank (Blood Banking) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Blood Bank (Blood Banking) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Blood Bank (Blood Banking) Sales Value (2021-2032) & (US$ Million) Figure 24. North America Blood Bank (Blood Banking) Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Blood Bank (Blood Banking) Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Blood Bank (Blood Banking) Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Blood Bank (Blood Banking) Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Blood Bank (Blood Banking) Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Blood Bank (Blood Banking) Sales Value (2021-2032) & (US$ Million) Figure 30. South America Blood Bank (Blood Banking) Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Blood Bank (Blood Banking) Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Blood Bank (Blood Banking) Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Whole Blood
  • Red Blood Cell
  • Platelet
  • Plasma
  • White Blood Cell
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • American Red Cross
  • Japan Red Cross Society
  • New York Blood Center
  • Sanquin Blood Supply Foundation
  • America’s Blood Centers
  • Canadian Blood Services
  • Shire (Baxalta)
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Sichuan Yuanda Shuyang
  • Abbott
  • Beckman Coulter
  • BD
  • Bio-Rad Laboratories
  • bioMérieux
  • Cerus
  • Haemonetics
  • Immucor
  • Fresenius Kabi
  • MacoPharma
  • Ortho-Clinical
  • Terumo BCT

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Blood Bank (Blood Banking) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Blood Bank (Blood Banking) Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Blood Bank (Blood Banking) Market Dynamics
  1. 2.1 Blood Bank (Blood Banking) Industry Trends
  2. 2.2 Blood Bank (Blood Banking) Industry Drivers
  3. 2.3 Blood Bank (Blood Banking) Industry Opportunities and Challenges
  4. 2.4 Blood Bank (Blood Banking) Industry Restraints
3 Blood Bank (Blood Banking) Market by Company
  1. 3.1 Global Blood Bank (Blood Banking) Company Revenue Ranking in 2025
  2. 3.2 Global Blood Bank (Blood Banking) Revenue by Company (2021-2026)
  3. 3.3 Global Blood Bank (Blood Banking) Company Ranking (2024-2026)
  4. 3.4 Global Blood Bank (Blood Banking) Company Manufacturing Base and Headquarters
  5. 3.5 Global Blood Bank (Blood Banking) Company Product Type and Application
  6. 3.6 Global Blood Bank (Blood Banking) Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Blood Bank (Blood Banking) Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Blood Bank (Blood Banking) Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Blood Bank (Blood Banking) Market by Type
  1. 4.1 Blood Bank (Blood Banking) Type Introduction
  2. 4.1.1 Whole Blood
  3. 4.1.2 Red Blood Cell
  4. 4.1.3 Platelet
  5. 4.1.4 Plasma
  6. 4.1.5 White Blood Cell
  7. 4.2 Global Blood Bank (Blood Banking) Sales Value by Type
  8. 4.2.1 Global Blood Bank (Blood Banking) Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Blood Bank (Blood Banking) Sales Value by Type (2021-2032)
  10. 4.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Type (2021-2032)
5 Blood Bank (Blood Banking) Market by Application
  1. 5.1 Blood Bank (Blood Banking) Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Blood Bank (Blood Banking) Sales Value by Application
  6. 5.2.1 Global Blood Bank (Blood Banking) Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Bank (Blood Banking) Sales Value by Application (2021-2032)
  8. 5.2.3 Global Blood Bank (Blood Banking) Sales Value Share by Application (2021-2032)
6 Blood Bank (Blood Banking) Regional Value Analysis
  1. 6.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Blood Bank (Blood Banking) Sales Value by Region (2021-2032)
  3. 6.2.1 Global Blood Bank (Blood Banking) Sales Value by Region: 2021-2026
  4. 6.2.2 Global Blood Bank (Blood Banking) Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Blood Bank (Blood Banking) Sales Value (2021-2032)
  7. 6.3.2 North America Blood Bank (Blood Banking) Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Blood Bank (Blood Banking) Sales Value (2021-2032)
  10. 6.4.2 Europe Blood Bank (Blood Banking) Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Blood Bank (Blood Banking) Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Blood Bank (Blood Banking) Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Blood Bank (Blood Banking) Sales Value (2021-2032)
  16. 6.6.2 South America Blood Bank (Blood Banking) Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Blood Bank (Blood Banking) Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Blood Bank (Blood Banking) Sales Value Share by Country, 2025 VS 2032
7 Blood Bank (Blood Banking) Country-level Value Analysis
  1. 7.1 Global Blood Bank (Blood Banking) Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Blood Bank (Blood Banking) Sales Value by Country (2021-2032)
  3. 7.2.1 Global Blood Bank (Blood Banking) Sales Value by Country (2021-2026)
  4. 7.2.2 Global Blood Bank (Blood Banking) Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Blood Bank (Blood Banking) Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Blood Bank (Blood Banking) Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Blood Bank (Blood Banking) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 American Red Cross
  2. 8.1.1 American Red Cross Company Information
  3. 8.1.2 American Red Cross Business Overview
  4. 8.1.3 American Red Cross Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  5. 8.1.4 American Red Cross Blood Bank (Blood Banking) Product Portfolio
  6. 8.1.5 American Red Cross Recent Developments
  7. 8.2 Japan Red Cross Society
  8. 8.2.1 Japan Red Cross Society Company Information
  9. 8.2.2 Japan Red Cross Society Business Overview
  10. 8.2.3 Japan Red Cross Society Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Japan Red Cross Society Blood Bank (Blood Banking) Product Portfolio
  12. 8.2.5 Japan Red Cross Society Recent Developments
  13. 8.3 New York Blood Center
  14. 8.3.1 New York Blood Center Company Information
  15. 8.3.2 New York Blood Center Business Overview
  16. 8.3.3 New York Blood Center Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  17. 8.3.4 New York Blood Center Blood Bank (Blood Banking) Product Portfolio
  18. 8.3.5 New York Blood Center Recent Developments
  19. 8.4 Sanquin Blood Supply Foundation
  20. 8.4.1 Sanquin Blood Supply Foundation Company Information
  21. 8.4.2 Sanquin Blood Supply Foundation Business Overview
  22. 8.4.3 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanquin Blood Supply Foundation Blood Bank (Blood Banking) Product Portfolio
  24. 8.4.5 Sanquin Blood Supply Foundation Recent Developments
  25. 8.5 America’s Blood Centers
  26. 8.5.1 America’s Blood Centers Company Information
  27. 8.5.2 America’s Blood Centers Business Overview
  28. 8.5.3 America’s Blood Centers Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  29. 8.5.4 America’s Blood Centers Blood Bank (Blood Banking) Product Portfolio
  30. 8.5.5 America’s Blood Centers Recent Developments
  31. 8.6 Canadian Blood Services
  32. 8.6.1 Canadian Blood Services Company Information
  33. 8.6.2 Canadian Blood Services Business Overview
  34. 8.6.3 Canadian Blood Services Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Canadian Blood Services Blood Bank (Blood Banking) Product Portfolio
  36. 8.6.5 Canadian Blood Services Recent Developments
  37. 8.7 Shire (Baxalta)
  38. 8.7.1 Shire (Baxalta) Company Information
  39. 8.7.2 Shire (Baxalta) Business Overview
  40. 8.7.3 Shire (Baxalta) Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shire (Baxalta) Blood Bank (Blood Banking) Product Portfolio
  42. 8.7.5 Shire (Baxalta) Recent Developments
  43. 8.8 CSL
  44. 8.8.1 CSL Company Information
  45. 8.8.2 CSL Business Overview
  46. 8.8.3 CSL Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CSL Blood Bank (Blood Banking) Product Portfolio
  48. 8.8.5 CSL Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Blood Bank (Blood Banking) Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 Octapharma
  56. 8.10.1 Octapharma Company Information
  57. 8.10.2 Octapharma Business Overview
  58. 8.10.3 Octapharma Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Octapharma Blood Bank (Blood Banking) Product Portfolio
  60. 8.10.5 Octapharma Recent Developments
  61. 8.11 Kedrion
  62. 8.11.1 Kedrion Company Information
  63. 8.11.2 Kedrion Business Overview
  64. 8.11.3 Kedrion Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Kedrion Blood Bank (Blood Banking) Product Portfolio
  66. 8.11.5 Kedrion Recent Developments
  67. 8.12 LFB Group
  68. 8.12.1 LFB Group Company Information
  69. 8.12.2 LFB Group Business Overview
  70. 8.12.3 LFB Group Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  71. 8.12.4 LFB Group Blood Bank (Blood Banking) Product Portfolio
  72. 8.12.5 LFB Group Recent Developments
  73. 8.13 Biotest
  74. 8.13.1 Biotest Company Information
  75. 8.13.2 Biotest Business Overview
  76. 8.13.3 Biotest Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Biotest Blood Bank (Blood Banking) Product Portfolio
  78. 8.13.5 Biotest Recent Developments
  79. 8.14 BPL
  80. 8.14.1 BPL Company Information
  81. 8.14.2 BPL Business Overview
  82. 8.14.3 BPL Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  83. 8.14.4 BPL Blood Bank (Blood Banking) Product Portfolio
  84. 8.14.5 BPL Recent Developments
  85. 8.15 RAAS
  86. 8.15.1 RAAS Company Information
  87. 8.15.2 RAAS Business Overview
  88. 8.15.3 RAAS Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  89. 8.15.4 RAAS Blood Bank (Blood Banking) Product Portfolio
  90. 8.15.5 RAAS Recent Developments
  91. 8.16 CBPO
  92. 8.16.1 CBPO Company Information
  93. 8.16.2 CBPO Business Overview
  94. 8.16.3 CBPO Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CBPO Blood Bank (Blood Banking) Product Portfolio
  96. 8.16.5 CBPO Recent Developments
  97. 8.17 Hualan Bio
  98. 8.17.1 Hualan Bio Company Information
  99. 8.17.2 Hualan Bio Business Overview
  100. 8.17.3 Hualan Bio Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Hualan Bio Blood Bank (Blood Banking) Product Portfolio
  102. 8.17.5 Hualan Bio Recent Developments
  103. 8.18 Sichuan Yuanda Shuyang
  104. 8.18.1 Sichuan Yuanda Shuyang Company Information
  105. 8.18.2 Sichuan Yuanda Shuyang Business Overview
  106. 8.18.3 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Sichuan Yuanda Shuyang Blood Bank (Blood Banking) Product Portfolio
  108. 8.18.5 Sichuan Yuanda Shuyang Recent Developments
  109. 8.19 Abbott
  110. 8.19.1 Abbott Company Information
  111. 8.19.2 Abbott Business Overview
  112. 8.19.3 Abbott Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Abbott Blood Bank (Blood Banking) Product Portfolio
  114. 8.19.5 Abbott Recent Developments
  115. 8.20 Beckman Coulter
  116. 8.20.1 Beckman Coulter Company Information
  117. 8.20.2 Beckman Coulter Business Overview
  118. 8.20.3 Beckman Coulter Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Beckman Coulter Blood Bank (Blood Banking) Product Portfolio
  120. 8.20.5 Beckman Coulter Recent Developments
  121. 8.21 BD
  122. 8.21.1 BD Company Information
  123. 8.21.2 BD Business Overview
  124. 8.21.3 BD Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  125. 8.21.4 BD Blood Bank (Blood Banking) Product Portfolio
  126. 8.21.5 BD Recent Developments
  127. 8.22 Bio-Rad Laboratories
  128. 8.22.1 Bio-Rad Laboratories Company Information
  129. 8.22.2 Bio-Rad Laboratories Business Overview
  130. 8.22.3 Bio-Rad Laboratories Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Bio-Rad Laboratories Blood Bank (Blood Banking) Product Portfolio
  132. 8.22.5 Bio-Rad Laboratories Recent Developments
  133. 8.23 bioMérieux
  134. 8.23.1 bioMérieux Company Information
  135. 8.23.2 bioMérieux Business Overview
  136. 8.23.3 bioMérieux Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  137. 8.23.4 bioMérieux Blood Bank (Blood Banking) Product Portfolio
  138. 8.23.5 bioMérieux Recent Developments
  139. 8.24 Cerus
  140. 8.24.1 Cerus Company Information
  141. 8.24.2 Cerus Business Overview
  142. 8.24.3 Cerus Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Cerus Blood Bank (Blood Banking) Product Portfolio
  144. 8.24.5 Cerus Recent Developments
  145. 8.25 Haemonetics
  146. 8.25.1 Haemonetics Company Information
  147. 8.25.2 Haemonetics Business Overview
  148. 8.25.3 Haemonetics Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Haemonetics Blood Bank (Blood Banking) Product Portfolio
  150. 8.25.5 Haemonetics Recent Developments
  151. 8.26 Immucor
  152. 8.26.1 Immucor Company Information
  153. 8.26.2 Immucor Business Overview
  154. 8.26.3 Immucor Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Immucor Blood Bank (Blood Banking) Product Portfolio
  156. 8.26.5 Immucor Recent Developments
  157. 8.27 Fresenius Kabi
  158. 8.27.1 Fresenius Kabi Company Information
  159. 8.27.2 Fresenius Kabi Business Overview
  160. 8.27.3 Fresenius Kabi Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Fresenius Kabi Blood Bank (Blood Banking) Product Portfolio
  162. 8.27.5 Fresenius Kabi Recent Developments
  163. 8.28 MacoPharma
  164. 8.28.1 MacoPharma Company Information
  165. 8.28.2 MacoPharma Business Overview
  166. 8.28.3 MacoPharma Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  167. 8.28.4 MacoPharma Blood Bank (Blood Banking) Product Portfolio
  168. 8.28.5 MacoPharma Recent Developments
  169. 8.29 Ortho-Clinical
  170. 8.29.1 Ortho-Clinical Company Information
  171. 8.29.2 Ortho-Clinical Business Overview
  172. 8.29.3 Ortho-Clinical Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Ortho-Clinical Blood Bank (Blood Banking) Product Portfolio
  174. 8.29.5 Ortho-Clinical Recent Developments
  175. 8.30 Terumo BCT
  176. 8.30.1 Terumo BCT Company Information
  177. 8.30.2 Terumo BCT Business Overview
  178. 8.30.3 Terumo BCT Blood Bank (Blood Banking) Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Terumo BCT Blood Bank (Blood Banking) Product Portfolio
  180. 8.30.5 Terumo BCT Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst